Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Neoplasms 86Breast Neoplasms 70Prostatic Neoplasms 34Head and Neck Neoplasms 26Lung Neoplasms 24Colorectal Neoplasms 24Ovarian Neoplasms 22Uterine Cervical Neoplasms 21Endometrial Neoplasms 16Brain Neoplasms 15Rectal Neoplasms 12Pancreatic Neoplasms 11Colonic Neoplasms 11Urinary Bladder Neoplasms 9Melanoma 9Lymphoma 9Leukemia 9Depression 9Stomach Neoplasms 8Pain 8Motor Activity 8Colorectal Neoplasms, Hereditary Nonpolyposis 8Sarcoma 7Oropharyngeal Neoplasms 7Multiple Myeloma 7Hematologic Neoplasms 7COVID-19 7Vulvar Neoplasms 6Health Behavior 6Glioma 6

Interventions

Surveys and Questionnaires 1Respiratory Function Tests 1Exercise Test 1Esophagectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Radiation Pneumonitis × Surveys and Questionnaires × Clear all
NCT01392144 2013-04-04

Phase II Evaluation of Exhaled Nitric Oxide (NO)

M.D. Anderson Cancer Center

Completed
36 enrolled
GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡